Viemed Healthcare, Inc.
General ticker "VMD" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $284.6M (TTM average)
Viemed Healthcare, Inc. follows the US Stock Market performance with the rate: 0.3%.
Estimated limits based on current volatility of 1.6%: low 6.68$, high 6.90$
Factors to consider:
- Total employees count: 1179 (+18.4%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market competition, Labor/talent shortage/retention, High capital expenditure requirements, Regulatory and compliance, Cybersecurity threats
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.56$, 11.15$]
- 2025-12-31 to 2026-12-31 estimated range: [7.46$, 12.43$]
Financial Metrics affecting the VMD estimates:
- Positive: with PPE of 28.7 at the end of fiscal year the price was very low
- Positive: 7.86 < Operating profit margin, % of 7.98
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.05 > 6.04
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of -9.86 <= -4.48
- Positive: 6.82 < Operating cash flow per share per price, % of 12.55
- Negative: negative Industry operating income (median)
- Positive: Inventory ratio change, % of -0.19 <= 0
- Negative: 0.01 < Interest expense per share per price, % of 0.25
Short-term VMD quotes
Long-term VMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $138.83MM | $183.01MM | $224.26MM |
| Operating Expenses | $130.58MM | $168.68MM | $206.36MM |
| Operating Income | $8.25MM | $14.33MM | $17.90MM |
| Non-Operating Income | $0.74MM | $0.06MM | $-1.73MM |
| Interest Expense | $0.20MM | $0.42MM | $0.78MM |
| R&D Expense | $2.70MM | $2.78MM | $3.07MM |
| Income(Loss) | $8.99MM | $14.39MM | $16.17MM |
| Taxes | $2.77MM | $4.15MM | $4.76MM |
| Profit(Loss)* | $6.22MM | $10.24MM | $11.27MM |
| Stockholders Equity | $97.09MM | $113.89MM | $131.39MM |
| Inventory | $3.57MM | $4.63MM | $4.32MM |
| Assets | $117.04MM | $154.90MM | $177.07MM |
| Operating Cash Flow | $27.75MM | $45.21MM | $39.09MM |
| Capital expenditure | $22.90MM | $26.09MM | $37.77MM |
| Investing Cash Flow | $-23.98MM | $-52.11MM | $-30.70MM |
| Financing Cash Flow | $-15.27MM | $2.83MM | $-3.69MM |
| Earnings Per Share** | $0.16 | $0.27 | $0.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.